abstract |
A method of inducing BEF-1 transcription factor comprising administering to a human in need thereof an effective amount of a compound having the formulan wherein R 1 and R 3 are independently hydrogen, -CH 3 ,n orn wherein Ar is optionally substituted phenyl; n R 2 is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof. |